ABSTRACT Autoradiographic localization of [3H~fluni-trazepam in nuclei of the rat cerebral cortex was further confirmed by biochemical analysis of specific nuclear binding. Highly purified rat cerebral cortex nuclei were shown to bind [IHlflunitrazepam specifically. The Kpp) for nuclear binding was 28 nM for the nuclei compared with a Kd(app) of 1.1 nM for binding of [3H]flunitrazepam to synaptosomal membrane fractions of the same tissue. Inhibition of the nuclear binding with inosine and hypoxanthine was greater than inhibition of the synaptic membrane fractions. These results lead us to conclude that specific binding may occur at both the synaptic membrane and the nuclear levels and that different endogenous ligands may compete at each site for binding. Furthermore, the possibility exists for translocation and alteration of the bound ligand complex from membrane site to nuclear site. It is now quite clear that specific sites exist in the brain for binding diazepam and certain structurally related ligands, all belonging to the class of compounds, the benzodiazepines. Diazepam is an extremely important drug because of its antianxiety effects with little apparent toxicity; it is also active as an anticonvulsant and a muscle relaxant.
[IHlflunitrazepam specifically. The Kpp) for nuclear binding was 28 nM for the nuclei compared with a Kd(app) of 1.1 nM for binding of [3H] flunitrazepam to synaptosomal membrane fractions of the same tissue. Inhibition of the nuclear binding with inosine and hypoxanthine was greater than inhibition of the synaptic membrane fractions. These results lead us to conclude that specific binding may occur at both the synaptic membrane and the nuclear levels and that different endogenous ligands may compete at each site for binding. Furthermore, the possibility exists for translocation and alteration of the bound ligand complex from membrane site to nuclear site. It is now quite clear that specific sites exist in the brain for binding diazepam and certain structurally related ligands, all belonging to the class of compounds, the benzodiazepines. Diazepam is an extremely important drug because of its antianxiety effects with little apparent toxicity; it is also active as an anticonvulsant and a muscle relaxant.
Binding of the benzodiazepines has been demonstrated in a large number of laboratories (1) (2) (3) (4) (5) (6) (7) (8) , and workers in these laboratories have shown that the binding exhibits many of the properties of a true pharmacologic receptor. However, because of the difficulty of providing good animal models for human anxiety, it has not been possible to prove that the binding site is a true neurohormone receptor. Studies have shown that although the binding site exhibits many of the requirements for being called a receptor site, the necessary requirement that the binding elicits a pharmacologic response has yet to be demonstrated.
Even though the true receptor nature of the binding has not been elucidated, several attempts have been made to isolate an endogenous ligand that inhibits the specific binding. Hypoxanthine and inosine in very high concentrations (mM) have been shown to partially inhibit the binding of [3H]benzodiazepine (9, 10), and a highly purified inhibitor isolated from urine has been described (11) . Other experiments (12) have been done to examine porcine brain fractions that contain entities between 500 and 100,000 Mr for competitive inhibition of specific benzodiazepine binding in rat brain subfractions, and inhibition by both high and low Mr fractions has been found. The high Mr (40,000-70,000) fraction, termed benzodiazepine-competitive factor I (BCF-I), was 5 times as potent as the low Mr (1000-3000) fraction (BCF-II). The designations BCF-I and BCF-II were chosen because the entities compete with benzodiazepines at their binding site (12 (14) . Sixty-nanometer sections were cut on an LKB Ultratome III, stained with uranyl acetate and lead citrate, and photographed on a Zeiss EM-1OA. For orientation and survey screening, 1-,m-thick sections were stained with toluidine blue.
Light Microscopic Autoradiography of Rat Whole Brain. Normal rats were given a bolus injection of 20 (2) . Forebrain sections of 150-to 200-g SpragueDawley or Holtzman rats were homogenized in 10 vol of 0.32 M sucrose, and the homogenate was centrifuged at 1000 X g for 10 min. Fractionation procedures for the brain sections have been described (2, 13); fraction B was used as the synaptosomal fraction. Purified nuclei were prepared as described below.
To determine the specific binding, we exposed 500,ul samAbbreviation: BCF, benzodiazepine-competitive factor. 1195
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 (18) . The nuclei were extremely pure and homogeneous. Purity of the preparation during the isolation procedure was monitored by light microscopy of preparations in 0.06% Azure C in 0.25 M sucrose. All nuclear preparations were assayed for the plasma membrane marker enzyme 5'-nucleotidase (19) The Scatchard analysis of the data (Fig. 4) 4 . Scatchard analysis of the data presented in Fig. 3 nucleus has high concentrations of purines and nucleosides and because nucleosides and purines bind to nuclear constituents such as DNA and histones, it is possible that the control mechanisms or endogenous ligand for benzodiazepines resides in molecular hypoxathine or inosine.
Because hypoxanthine and inosine do not inhibit [3H]flunitrazepam as much at the synaptosomal membrane, it is possible that control mechanisms or endogenous ligand activity may reside in the polypeptide BCF-I and BCF-II inhibitors which have been described (12) . In any event, it is obvious that the two sites of specific binding allow for more than one endogenous inhibitor to be active.
In conclusion, although a true receptor mechanism has not been established for the benzodiazepine binding to nuclei, the specific binding has been described. Aside from the pharmacologic importance, the elucidation of just what role the flunitrazepam nuclear binding plays in the molecular action of benzodiazepines should prove exciting.
